We have developed a new and highly efficient α-specific glucosylation method based on the synergistic α-directing effects of a TolSCl/AgOTf promoter system and the steric β-shielding or the remote participation of protecting groups at the donor 6- O -position.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: